SUPN
Supernus Pharmaceuticals Inc
$49.38
+1.42% (+$0.69)
Volume
529,463
52W High
$59.68
52W Low
$30.83
Market Cap
$2.83B
Next Earnings Report
Last Reported
May 6, 2026 Missed
Actual: $0.21
vs. Consensus: $0.28
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q1 2026
May 6, 2026
1-Day:
+1.61%
5-Day:
-4.04%
Q1 2026
May 5, 2026
1-Day:
+4.59%
Q1 2026
Mar 31, 2026
1-Day:
-0.48%
Q4 2025
Mar 3, 2026
1-Day:
+1.87%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $211.6M | +21.5% | 89.1% | 6.5% | -$4.1M |
| Q3'25 | $192.1M | +9.3% | 74.8% | -31.4% | -$45.1M |
| Q2'25 | $165.5M | -1.7% | 89.8% | 7.3% | $22.5M |
| Q1'25 | $149.8M | +4.3% | 89.5% | -6.9% | -$11.8M |
| Q4'24 | $174.2M | +6.0% | 85.0% | 12.3% | $15.3M |
| Q3'24 | $175.7M | +14.2% | 90.0% | 23.3% | $38.5M |
| Q2'24 | $168.3M | +24.2% | 89.4% | 13.4% | $19.9M |
| Q1'24 | $143.6M | -6.6% | 88.7% | -2.2% | $124,000 |
Company Information
Symbol
SUPN
Company
Supernus Pharmaceuticals Inc
Market Cap
$2.83B